Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - tbi+-+traumatic+brain+injury
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
STING Agonist 8803 for Blood-Brain Barrier Opening in Glioblastoma Treatment
SHORT DESCRIPTION Chemical compound that opens the blood-brain barrier to enhance delivery of therapeutics for treating glioblastoma. INVENTORS Amy Heimberger* Northwestern University Feinberg School of Medicine, Department of Neurological Surgery * Principal Investigator NU 2025-212 IP...
Published: 4/29/2026
|
Updated: 4/27/2026
|
Inventor(s):
Keywords(s):
AD - Alzheimer’s Disease
,
Adjunct therapy
,
ALS - Amyotrophic Lateral Sclerosis
,
Animal Model
,
Autoimmune disease
,
Bladder cancer
,
Brain cancer
,
Breast cancer
,
Cancer Treatment
,
Cancer/Oncology
,
Cervical cancer
,
CNS - Central Nervous System
,
Colon cancer
,
Drug delivery
,
Endometrial cancer
,
Gastric cancer
,
GBM - Glioblastoma
,
Head and neck cancer
,
Immunology
,
Immunotherapy
,
Liver cancer
,
Lung cancer
,
MS - Multiple Sclerosis
,
Neurodegenerative disease
,
Neurologic disease
,
Ovarian cancer
,
Pancreatic cancer
,
PD - Parkinson's Disease
,
Prostate cancer
,
Repurposed Drugs
,
Research tool
,
Small molecule
,
Targeted therapy
,
TBI - Traumatic brain injury
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
,
Life Sciences > Biomarkers & Biomedical Research Tools
Selective PAD2 Inhibitors for Neuroprotection in Traumatic Brain Injury
SHORT DESCRIPTION Novel PAD2-selective inhibitor platform targeting neuroinflammation to support both acute neuroprotection and long-term functional recovery as a first-in-class treatment of traumatic brain injury. INVENTORS Hasan Alam* Northwestern University Feinberg School of Medicine, Department of Surgery (Trauma...
Published: 4/27/2026
|
Updated: 4/27/2026
|
Inventor(s):
Keywords(s):
CNS - Central Nervous System
,
CVA - Cerebrovascular Accident
,
Neurodegenerative disease
,
Neuroinflammation
,
Neurologic disease
,
Neurology
,
Small molecule
,
Targeted therapy
,
TBI - Traumatic brain injury
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Recombinant Annexin Therapy for Muscle, Cardiac, and Neuronal Cell Membrane Repair
NU 2022-008 SHORT DESCRIPTION An annexin-based biological therapeutic that enhances the body's natural cell membrane repair process to reduce skeletal muscle, cardiac, and neuronal cell death and preserve tissue function. INVENTORS INVENTORS Elizabeth McNally* Feinberg School of Medicine, Department of Medicine (Cardiology...
Published: 4/14/2026
|
Updated: 4/14/2026
|
Inventor(s):
Keywords(s):
Biologic
,
Cardiomyopathy
,
DMD - Duchenne muscular dystrophy
,
Inflammation
,
Membrane injury and repair
,
Neurodegenerative disease
,
Rare diseases
,
SCI - Spinal cord injury
,
TBI - Traumatic brain injury
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Immunomodulatory Nanoparticles for the Therapeutic Intervention of Traumatic Brain Injury
NU 2019-030 INVENTORS John Kessler Sripadh Sharma ABSTRACT There is no decisive treatment for traumatic brain injury (TBI). After the primary trauma, secondary injury, largely mediated by blood-borne immune cells called monocytes, takes place causing damage to surrounding healthy cells. Furthermore, cellular and whole brain swelling (edema) resulting...
Published: 1/14/2026
|
Updated: 5/27/2022
|
Inventor(s):
Keywords(s):
Autoimmune disease
,
CNS - Central Nervous System
,
Immunology
,
Inflammation
,
Neurologic disease
,
Neurology
,
Targeted therapy
,
TBI - Traumatic brain injury
,
Therapeutics
Category(s):
Life Sciences > Therapeutics